Skip to content
HowShorted

ABEONA THERAPEUTICS INC. short interest in 2020

In 2020, ABEONA THERAPEUTICS INC.'s disclosed short interest ran from 9.01% of shares outstanding on 15 Jan 2020 to 2.72% on 31 Dec 2020, a change of -6.29 percentage points. The year's high was 10.62% on 14 Feb 2020 and its low 1.39% on 30 Nov 2020, averaging 4.42% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 5.71 days on 31 Jul 2020. Full history: ABEONA THERAPEUTICS INC..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for ABEONA THERAPEUTICS INC. in 2020

2020 in figures

Start of year
9.01% (15 Jan 2020)
End of year
2.72% (31 Dec 2020)
Change
-6.29 pp
High
10.62% (14 Feb 2020)
Low
1.39% (30 Nov 2020)
Average
4.42%
Highest days to cover
5.71 (31 Jul 2020)
SEC filings marked
8

Every report in 2020

ABEONA THERAPEUTICS INC. short interest in 2020
SettlementShort interestDays to coverFilings since previous
15 Jan 20209.01%2.34
31 Jan 20209.63%4.11
14 Feb 202010.62%3.57
28 Feb 20209.05%1.94
13 Mar 20204.52%2.68
31 Mar 20204.92%2.5810-K filed, results (8-K)
15 Apr 20204.84%3.43
30 Apr 20204.88%4.69
15 May 20204.89%2.9110-Q filed, results (8-K)
29 May 20202.59%3.06
15 Jun 20203.40%3.16
30 Jun 20203.63%3.50
15 Jul 20203.57%2.46
31 Jul 20203.63%5.71
14 Aug 20202.48%4.5110-Q filed, results (8-K)
31 Aug 20202.63%2.92
15 Sep 20202.63%2.93
30 Sep 20202.62%1.00
15 Oct 20203.10%1.00
30 Oct 20204.09%2.71
13 Nov 20202.85%1.3310-Q filed, results (8-K)
30 Nov 20201.39%1.00
15 Dec 20202.29%1.30
31 Dec 20202.72%1.09

See also: ABEONA THERAPEUTICS INC.'s full history · most shorted US stocks of 2020 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.